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Abstract 
Venue-based distribution of marijuana has become the normative model in the United States to 
obtain marijuana. This study examines one-time purchase behaviors at medical marijuana 
dispensaries (MMDs) to identify potential venue- and individual-level targets for prevention. We 
used a two-stage, venue-based sampling approach to randomly select patrons exiting 16 MMDs 
in Los Angeles, California during the spring of 2013. Patrons (N = 595) reported their discrete 
purchase behaviors during their most recent visit to the sampled MMD. We used hierarchical 
linear modeling to examine the amount spent on marijuana products, regressed on characteristics 
of the sampled dispensaries and their patrons. We used hierarchical generalized linear modeling 
to examine the likelihood of purchasing specific types of marijuana products and total grams of 
loose-leaf buds purchased. Patrons spent US$41.73 on average, with a range of $0 to $330. We 
observed significant variation in purchase behaviors across MMDs and associations between 
venues located within high median income census tracts and a higher total amount spent and 
lower odds of purchasing only loose-leaf buds. The networked distance between a patron’s home 
and the sampled MMD was positively associated with the total amount spent and total quantity 
of buds purchased. We also found significant relationships between medical conditions reported 
for use in three models: total amount spent, purchase of pre-rolled joints, and total grams of buds 
purchased. Policy makers may want to explore regulating the availability of specialty items that 
may be attractive to naïve users, such as pre-rolled joints or edibles, or high-concentration 
products that may be sought out by regular, heavy users. 
 Keywords: Medical marijuana dispensaries, Purchasing behaviors, Marijuana product 
type, Venue-based sampling 
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Internationally, marijuana policies are shifting towards social allowance, as evidenced by 
an increasing number of countries supporting decriminalization, medical use, and/or recreational 
use (Grund & Breeksema, 2013; Reuter, 2010). In the United States, this shift is indicated by the 
increasing number of states (now 31 states, the District of Columbia, Guam and Puerto Rico) that 
as of 2018 permit marijuana use for medicinal and/or recreational purposes (National Conference 
of State Legislatures, 2018). In addition, the use of venue-based distribution of marijuana is the 
normative model within most of these states (Berg, Henriksen, Caboszos-Reng, Haardoerrer, & 
Freisthler, 2018; National Conference of State Legislatures, 2018). In this context, policies that 
are aimed at regulating medical marijuana dispensaries (MMDs) to influence marijuana 
consumption behaviors need to be informed by data concerning who are using these venues, the 
types and quantities of products obtained through these venues, and MMD- and individual-level 
characteristics related to these purchase behaviors.  
Our knowledge about medical marijuana users has increased dramatically in the past 
decade. Although users remain predominantly White and non-Hispanic males (Azofeifa, 
Sherman, Mattson, & Pacula, 2018; Lankenau et al., 2018; Lin, Ilgen, Jannausch, & Bohnert, 
2016; O’Connell & Bou-Matar, 2007; Ryan-Ibarra, Induni, & Ewing, 2014), these demographics 
are not consistent across geographic regions and are not static over time. Prior work reported that 
the proportion of White and non-Hispanic users range between 29% to 85%, and these numbers 
likely are dependent on the sampling approach used, U.S. region, and range of ages sampled 
(Bohnert et al., 2018; Bonn-Miller, Boden, Bucossi, & Babson, 2014; Haug et al., 2017; Kepple 
& Freisthler, 2017; Kepple, Mulholland, Freisthler, & Schaper, 2016; Lankenau et al., 2018; 
Nunberg, Kilmer, Pacula, & Burgdorf, 2011; O’Connell & Bou-Matar, 2007). In addition, 
Fairman (2016) observed that the proportion of men (relative to women) registering for medical 
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marijuana participation has decreased over time in an analysis of 13 U.S. states and the District 
of Columbia. Recent trends also indicate a growing proportion of younger medical marijuana 
users (18–30 years old; Fairman, 2016).  
Studies have consistently reported the following medical conditions for medicinal 
marijuana use (ranked from most to least common): pain (predominantly nonspecific chronic 
pain), mental health conditions (predominantly anxiety disorders and sleep problems), 
gastrointestinal problems (predominantly nausea or appetite stimulant), neurological problems 
(predominantly headaches), and other chronic conditions such as HIV/AIDS, cancer, or 
glaucoma (Abuhasira , Schleider, Mechoulam, & Novack, 2018; Lankenau et al., 2018; Nunberg 
et al., 2011; Park & Wu, 2017). For many of these conditions, individuals report medical 
marijuana use as a substitute for prescription medication (Piper et al., 2017). Regarding use 
patterns, the vast majority of studies have shown that medical marijuana users overwhelmingly 
indicate daily or near daily use of these products and average quantities between 2g to 8g per 
week (Bohnert et al., 2018; Bonn-Miller et al., 2014; Haug et al., 2017; Lin et al., 2016; 
O’Connell & Bou-Matar, 2007).  
We know less about how MMDs are shaping purchase behaviors (e.g., the financial 
resources being spent, variation in products or quantity obtained) and how these behaviors may 
differ across the previously discussed user characteristics. Purchase behaviors matter, given that 
different marijuana user groups (defined by demographics, reason for use, and/or marijuana 
consumption patterns) are likely to respond differently to shifts in product supply such as pricing 
and potency (Pacula & Lundberg, 2014; Pacula & Sevigny, 2014). Market-specific factors, such 
as cost or product diversity, may influence new or light users more than heavy users with 
cannabis dependence (Aston, Metrik, & MacKillop, 2015). Recent work also suggests 
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dispensaries may be creating niche markets that attract individuals to their specific locations; 
thus, venue-level factors, such as product diversity or external dispensary characteristics like its 
physical condition or security features, may influence purchasing behaviors (Cooke, Freisthler, 
& Mulholland, 2018; Kepple & Freisthler, 2017). 
Two prior studies provide a foundation for the importance of exploring correlates of 
purchase behaviors. The first is a pilot study that used a convenience sample of four dispensaries 
and a small sample of exiting patrons (N = 106); it observed higher amounts spent on a one-time 
purchase among individuals who were older or who identified receiving a marijuana 
recommendation for mental health symptoms, compared with those for a specified physical 
condition (Kepple et al., 2016). Another study observed a higher likelihood of purchasing edibles 
by patrons exiting dispensaries located in census tracts with higher median incomes and with a 
higher number of surrounding dispensaries located within 0.5 km (Kepple & Freisthler, 2017). 
The prior studies did not observe significant relationships between distance-travelled and amount 
spent or purchase of edibles (Kepple & Freisthler, 2017; Kepple et al., 2016). Similarly, Caulkins 
& Pacula (2006) observed that individuals who illicitly purchased marijuana at locations close to 
their home did not differ in total purchase cost from those purchasing elsewhere. However, these 
studies did not explore how the distance travelled by patrons may be associated with quantity of 
the product obtained (Caulkins & Pacula, 2006; Kepple & Freisthler, 2017; Kepple et al., 2016). 
In addition, these studies did not examine the purchase of specialty products like pre-rolled joints 
or concentrates that have been made more accessible through MMDs (Borodovsky, Crosier, Lee, 
Sargent, & Budney, 2016). Understanding these behaviors would help illuminate MMD- and 
individual-level correlates associated with purchasing these easy-to-use products that can be 
more attractive to the naïve user (Hancock-Allen, Barker, VanDyke, & Holmes, 2015) and with 
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purchasing high concentrate products that can have adverse and even toxic effects (Alzghari, 
Fung, Rickner, Chacko, & Fleming, 2017; Russell, Rueda, Room, Tyndall, & Fischer, 2018).  
Study Aims 
We sought to provide more comprehensive information about how patrons are using 
MMDs to better inform place-based regulations. To examine how patrons in Los Angeles, 
California were using MMDs, we asked the following exploratory research questions: 
1. What are the types of one-time purchase behaviors that were observed among patrons 
exiting MMDs?  
2. What venue- and patron-level characteristics are associated with the following one-
time purchase behaviors from a MMD: 
a. Financial resources spent (i.e., total cost of purchase)? 
b. Type of medical marijuana product obtained? 
c. Total quantity (in grams) of loose-leaf buds obtained? 
Methods 
Study Design and Sampling Procedures 
We used four sources of information: (a) a premises survey, (b) an exit survey, (c) online 
MMD directories, and (d) U.S. Census estimates (Geolytics, 2015). We conducted this study 
with the approval of the University of California, Los Angeles institutional review board. 
Premises survey. We created a de-duplicated list of 875 unique dispensary locations by 
combining a list of registered dispensaries with the City of Los Angeles Department of Finance; 
registries of dispensaries from websites (e.g., Weedmaps); and trade publications with 
advertisements for dispensaries (e.g., LA Weekly). We geocoded dispensary locations using Arc 
GIS 10.3. Trained research staff verified that 475 locations were operating during the summer of 
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2012 through systematic observations using a premises survey of the exterior factors that 
included signage, exterior condition, and security features.  
Exit survey. The exit survey used a two-stage, venue-based sampling procedure. First, 
we randomly sampled 16 MMDs from the list of 475 operating locations. A team of trained 
research staff conducted surveys outside each location during three different two-hour time 
periods between 10 am and 6 pm. We sampled exiting patrons using a random start (i.e., 
determined by a roll of a die) with systematic sampling (i.e., researchers approached the second 
person to exit dispensary after completing an interview) until 40 exit surveys were completed for 
each sampled MMD or the sampling time period ended. We approached a total of 705 dispensary 
patrons, 18 years of age or older. The survey response rate was 84%, resulting in 595 patrons 
reporting on their demographic characteristics, conditions associated with their medical 
marijuana recommendation, and items purchased during their most recent visit to a sampled 
dispensary. All participants completed a written informed consent. The in-person survey lasted 3 
to 5 min, and we compensated participating individuals with $20 in cash. (See Table 1 for patron 
characteristics.)  
<INSERT TABLE 1 ABOUT HERE> 
A prior study examined sample bias arising from these procedures and determined that 
minimal nonresponse bias was present using these sampling techniques (Thomas & Freisthler, 
2016). That being said, this study observed one key difference between nonparticipating (n = 37) 
and participating (n = 16) sampled MMDs: participating dispensaries tended to carry more novel 
products, such as concentrates (e.g., honey oil, hashish), which may influence the type of 
products patrons reported purchasing in this study. In this same analysis, a comparison of 
individuals who chose to participate in the exit survey with those who chose to decline indicated 
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that exiting patrons who self-identified as Black/African American or Hispanic were more likely 
to participate in the exit survey.  
Online directories and U.S. Census estimates. Using a computer script, we 
systematically pulled data from six online directories for MMDs. We triangulated information 
from these sources to record type of products sold and whether credit cards were accepted. When 
available, we tracked the low- and high-end prices per gram for three strains of marijuana buds 
(i.e., indica, sativa, and hybrid). These data represent a point-in-time snapshot based on data 
pulled during May 2013. Finally, we used 2012 GeoLytics estimates to obtain demographics of 
the census tract where each MMD was located (Geolytics, 2015). Table 2 shows a summary of 
characteristics for the 16 sampled MMDs. 
<INSERT TABLE 2 ABOUT HERE> 
Measures 
Purchase behaviors. Table 3 describes the types of purchase behaviors reported by 
respondents exiting sampled MMD locations.  Respondents self-reported the total amount spent 
during their most recent visit in dollar amounts ($US). We operationalized the type of products 
purchased using a series of mutually nonexclusive dichotomized variables indicating whether 
respondents self-reported the purchase of: (a) loose-leaf buds, (b) edibles, (c) concentrates, (d) 
pre-rolled joints, (e) seeds or clones, (f) loose-leaf buds only, and (g) multiple types of products. 
For the subset of individuals who reported purchasing loose-leaf buds (n = 500), we calculated 
self-reported quantity of loose-leaf buds purchased (in grams). We also categorized self-reported 
type of strain purchased into the following mutually nonexclusive dichotomous variables: (a) 
indica, (b) sativa, (c) hybrid, and (d) multiple strains.  
<INSERT TABLE 3 ABOUT HERE> 
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Individual characteristics. Respondents self-reported their gender, age (in years), race, 
and ethnicity. Respondents identified the ethnic and racial identities that best defined them, 
which we then recoded into four categories: (a) White and non-Hispanic, (b) Black and non-
Hispanic, (c) Hispanic, and (d) other racial/ethnic group.  
Respondents reported the specific medical conditions for which they obtained their 
medical marijuana recommendation. We categorized these medical conditions into six mutually 
nonexclusive variables: (a) pain, which included chronic pain (nonspecific), arthritis, injury-
related pain, neuropathy/nerve pain, or other pain-related conditions; (b) mental health condition, 
comprising sleep problems, anxiety, depression, bipolar disorder, PTSD, and/or ADD/ADHD; 
(c) gastrointestinal condition, for which respondents indicated use for stimulating appetite 
(nonspecific), Crohn’s disease, anorexia, and/or other metabolic disorders; (d) neurological 
condition, which comprised migraines, MS/spasticity, epilepsy/seizures, and/or TMJ; (e) other 
chronic medical condition, comprising glaucoma or other eye condition, cancer-related 
symptoms, asthma, HIV/AIDS, tinnitus and/or autism; and (f) nonmedical condition, comprising 
stress, happiness, restlessness, and skin care.  
Respondents also reported the nearest intersection to their home address. We calculated 
networked distances using ESRI U.S. and Canada Detailed Streets (ESRI, 2010) and ArcGIS 
10.3 Network Analyst extension (ESRI, 2015) to obtain the shortest networked distance (in 
meters) from the respondent’s approximate home location to the sampled dispensary’s location. 
We winsorized the distance travelled for 22 respondents residing outside of Los Angeles 
(including outside the State of California) to the largest distance reported by respondents residing 
within Los Angeles County. 
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MMD characteristics. We used 2012 GeoLytics estimates (Geolytics, 2015) of 
population density (1,000 population per square mile), median income (in US$1,000), and 
percent of population who identified as White and non-Hispanic for the census tract where each 
MMD was located. We calculated the number of MMD locations within a 0.5 km buffer of each 
sampled MMD site using ArcGIS 10.3 Buffer Analysis. We categorized MMD licensure status 
to distinguish between locations that were (a) licensed prior to the 2007 City of Los Angeles 
moratorium and remained eligible for licensure, (b) licensed prior to 2007 but are no longer 
eligible for licensure due to change in management, and (c) not licensed. 
During the premises survey, trained research staff rated exterior maintenance on a 4-point 
scale and provided textual descriptions of the site: (1) excellent (very clean, recent paint or 
remodel); (2) good (no trash or peeling paint); (3) fair (minor disrepair; some trash); and (4) poor 
(graffiti, broken windows, lots of trash). We recoded these responses into a categorical measure 
of poor exterior condition: good to excellent (0) or poor to fair (1). In addition, we summed the 
total number of outside security features that we coded by presence (1) or absence (0): (a) locked 
metal screen door, (b) pass-through door, (c) intercom, (d) doorman, (e) security cameras, and (f) 
signs about IDs/Rx requirements.  
Using information from online directories, we categorized diversity of dispensary 
inventory into three levels: (1) low (sell primarily loose-leaf buds); (2) moderate (sell a mix of 
product types but not a full range of products); and (3) high (sell the full range of products that 
include loose-leaf buds, edibles, concentrates, pre-rolled joints, and seeds/clones). We also 
categorized whether credit cards were accepted (1) or not accepted (0). 
Analytic Procedures 
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We examined correlates of a one-time purchase of marijuana products for the 517 patrons 
who reported making any purchase and provided complete data (35 per dispensary on average, 
range = 19 to 42). We used several multilevel models to estimate unadjusted and adjusted 
relationships for five dependent variables: (a) hierarchical linear model (HLM) for total amount 
spent (in natural log-transformed $US); (b) hierarchical generalized linear model (HGLM) using 
a Bernoulli sampling model and a log-link function for purchase of loose-leaf buds only, pre-
rolled joints, and concentrates; and (c) HGLM using a Poisson sampling model and a log-link 
function for total quantity of loose-leaf buds purchased (in grams). Each model regressed the 
dependent variable on characteristics of sampled dispensaries (level 2) and their patrons (level 
1); coefficients were exponentiated for all models (Raudenbush & Bryk, 2002).  
We grand mean centered the Level 2 variables used in the final models (i.e., census tract 
median income and MMD density; Raudenbush & Bryk, 2002). Median income was 
significantly correlated with ratings of poor exterior maintenance of a building, t(14) = 2.175, p 
< .047, and high diversity of product, t(14) = -2.359, p < .033; median income was kept in the 
final models in lieu of the other two measures because it resulted in better model fit. Level 1 
independent variables included patrons’ demographics, medical conditions, and distance 
travelled (in natural log-transformed meters). Models also controlled for types of products 
purchased when appropriate. We conducted all analyses using HLM 7 with a default setting 
using restricted maximum likelihood to estimate the model (Raudenbush, Bryk, Cheong, 
Congdon, & du Toit, 2011).  
For all models, we removed cases with missing data (n = 30; 5.5% of sample). Missing 
data varied significantly across MMD locations, primarily driven by 10 respondents with missing 
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data at one dispensary location, χ2 (15) = 57.044, p < .001; all other dispensaries had missing 
data for a range of 0 to 3 respondents.  
Results 
All 16 dispensary locations sold loose-leaf buds and edibles at a minimum. The sample 
was predominantly male and racially/ethnically diverse; the average age was 34 years old (see 
Table 1 for more details). Patrons reported pain management (54%) or a mental health condition 
(60%) as the primary reasons for medical marijuana use. Pain was primarily comprised of 
chronic pain (46%), and mental health condition was primarily comprised of anxiety (32%) and 
sleep problems (38%).  
Range of Purchase Behaviors 
Descriptive statistics reported in Table 3 show the diverse range of purchase behaviors. 
Approximately 92% of respondents reported making a purchase during their most recent visit to 
the dispensary. Of those who reported obtaining products, exiting patrons spent US$41.73 on 
average (SD = US$43.90) with a range of US$0 (obtaining free promotional items) to US$330 
(on marijuana buds only) during a one-time visit. The great majority of patrons reported 
purchasing loose-leaf buds only (n = 381; 76% of sampled reporting any purchase). Among the 
166 patrons who reported purchasing other products besides buds, we observed a high amount of 
variability in the types and combination of products purchased. 
Correlates of Total Amount Spent (Natural Log-Transformed US$) 
Table 4 shows the results of the final conditional HLM for total amount spent (i.e., 
adjusted for level-1 predictors plus conditional random slopes and intercept coefficient for level-
2). The geometric mean of the total amount spent at a “typical” dispensary is US$17.70 when 
holding all variables constant. The exponentiated coefficients reported in Table 4 indicate the 
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proportion of increase or decrease in this geometric mean. For example, a 10-unit (or $10,000) 
increase in census tract median income is associated with an expected increase in total amount 
by about 7% when holding all other variables constant. Reporting use for gastrointestinal and 
neurological conditions is associated with an expected decrease in total amount spent by about 
23% and 29%, respectively. Patrons identifying as an age category older than 24 or having 
travelled a further distance are associated with higher total amount spent. Identifying as White 
and non-Hispanic is associated with higher amount spent compared with identifying as Hispanic 
or Black and non-Hispanic.  
<INSERT TABLE 4 ABOUT HERE> 
Correlates of Type of Marijuana Product 
We only report the significant results for the analyses discussed in this section; detailed 
tables are available as online supplemental files. In the final conditional HGLM for purchasing 
only loose-leaf buds, we observed no significant associations with any individual-level factors; 
in contrast, we observed that the MMD-level factor of census tract median income is associated 
with lower odds of purchasing buds only (OR = 0.983, 95% CI [0.969,0.997], p = 0.021). In the 
final conditional HGLM for purchase of pre-rolled joints, patrons who reported use for other 
chronic medical conditions are more likely to purchase pre-rolled joints (OR = 2.518, 95% CI 
[1.006, 6.300], p = .048).  
The number of respondents who reported purchasing concentrates was too low to 
establish reliable multivariate models; we describe the significant findings from our exploratory 
bivariate models here. The unadjusted HGLMs for purchasing concentrates indicated that men 
are 75% more likely to purchase concentrates than women (OR = 3.019, 95% CI [1.046, 8.714], 
p =.041) and respondents who self-identified as White and non-Hispanic are associated with 
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double the odds of purchasing concentrates compared to all other racial/ethnic groups (OR = 
2.196, 95% CI [1.138, 4.238], p = .019). In addition, respondents who purchase multiple types of 
products are more likely to purchase concentrates (OR = 16.478, 95% CI [7.509, 36.165], p < 
.001), and patrons who purchase buds are less likely to purchase concentrates (OR = 0.152, 95% 
CI [0.071, 0.329], p < .001).  
Correlates of Total Grams of Loose-Leaf Buds (in Grams) 
Table 5 shows the results of the final conditional HGLM for total grams of buds 
purchased with event rate ratios (ERR) reported; ERRs should be interpreted as the change in 
expected quantity of buds purchased (in grams). For example, the expected quantity of buds (in 
grams) for a one-time purchase is 11% lower for individuals who purchased only loose-leaf 
buds; in contrast, it is double the amount for individuals who purchased multiple strains of 
marijuana. The expected quantity of buds (in grams) is 18% lower for patrons reporting use for 
gastrointestinal conditions (compared with other medical conditions). The final model estimated 
that a higher count of buds in grams is expected for a patron identifying as male, in age 
categories older than 24, or having travelled a farther distance. Finally, identifying as White and 
non-Hispanic is associated with higher expected counts in grams compared with identifying as 
Black and non-Hispanic or other racial/ethnic groups. 
<INSERT TABLE 5 ABOUT HERE> 
Discussion 
We observed a high diversity of products sold across dispensaries and a diverse range of 
purchase behaviors across individuals. The descriptive analyses highlighted that while average 
costs and quantity of buds purchased are relatively low; approximately a quarter of the sample 
spent anywhere from $50 to $330 at one time. In addition, 14% of individuals who purchased 
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buds reported obtaining higher than the average weekly quantities that were reported across prior 
studies (Bohnert et al., 2018; Bonn-Miller et al., 2014; Haug et al., 2017; Lin et al., 2016; 
O’Connell & Bou-Matar, 2007). Approximately a quarter of all purchasers selected specialty 
products that require simpler modes of preparation (i.e., ready-made edibles or pre-rolled joints) 
or higher concentration of THC (i.e., edibles or concentrates like hash oil). About 17% of all bud 
purchasers obtained multiple strains of marijuana, which mirrors prior findings that individuals 
are likely to report the use of multiple strains (Piper et al., 2017).  
Interestingly, patrons who purchased multiple strains of marijuana are expected to 
purchase a larger quantity of buds than patrons purchasing one strain. This association makes 
sense in light of a minimum 1g purchase quantity within these stores and prior work suggesting 
user perceptions of differential strain effects (Corral, 2001; Piper et al., 2017). Further work 
should explore why individuals are selecting strains of marijuana, such as correspondence to 
specific conditions and/or combination of conditions, to understand their need for multiple 
strains (Corral, 2001; Piper et al., 2017).  
This study also provided insights into patron- and venue-level characteristics associated 
with a range of one-time purchase behaviors reported by individuals exiting a random sample of 
MMDs. Regarding demographic correlates, 18 to 24-year-old patrons spent less and obtained 
smaller quantities of loose-leaf buds on average than older age categories. These are important 
findings to further explore, given the demographic trends that younger age groups may be 
increasing their use of medical marijuana (Fairman, 2016). In addition, we observed different 
patterns in purchase behaviors by racial and ethnic identification. Specifically, Black and non-
Hispanic patrons spent less and purchased less grams of buds on average than White and non-
Hispanic patrons. While we observed that Hispanic patrons spent less during a one-time visit, 
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they did not purchase fewer grams than White and non-Hispanic patrons. Further exploration is 
needed to evaluate how differences in purchase behaviors for these demographic groups may be 
better explained by patrons’ availability of discretionary income, frequency of visits to a 
dispensary, level of experience (i.e., naïve vs. regular), and frequency of use of products (i.e., 
light vs. heavy).  
We observed that men are more likely than women to purchase higher quantities of buds 
(in grams). Our exploratory bivariate analyses also suggested that men are more likely to 
purchase concentrates, which is consistent with prior work (Daniulaityte et al., 2017). 
Concentrate users typically are more experienced and are heavy users (Daniulaityte et al., 2017), 
which would also align with our bivariate findings that patrons purchasing concentrates have 
higher odds of purchasing multiple types of products. Finally, distance travelled was positively 
correlated with amount spent and quantity of buds obtained. Our findings differ from prior 
studies that observed no correlation between distance and amount spent, possibly due to our use 
of a more precise distance measure, randomly selected MMDs from which to sample, or a larger 
sample size (Caulkins & Pacula, 2006; Kepple & Freisthler, 2017; Kepple et al., 2016).  
For medical conditions, patrons who reported use for gastrointestinal and neurological 
conditions spent less, on average. For gastrointestinal conditions, we also observed lower counts 
of buds (in grams) than those not reporting these conditions. It may be that users reporting these 
conditions engage in lighter use of marijuana products than those who report use for pain 
management, mental health, other chronic conditions, or non-medical conditions. In addition, 
specialty products like pre-rolled joints were associated with use for other chronic medical 
conditions, like symptoms related to HIV/AIDs or cancer. Pre-rolled joints may provide easier 
access for naïve users, which could be beneficial for individuals who are new to use and need it 
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for medical conditions. The lack of significant differences for individuals reporting pain or 
mental health conditions may be that medicinal use to treat some conditions is driven by personal 
choice (e.g., preference for mode of consumption), needs specific to the severity or chronicity of 
the condition, or available financial resources. These larger variations in purchase behaviors 
within medical condition categories are concerning in light of the lack of clear guidelines 
available for marijuana use by specific conditions (MacCallum & Russo, 2018). Future research 
is needed to better understand how these unmeasured factors may contribute to potential 
disparities in access to and quality of medical marijuana products. 
  At the venue level, we observed the median income of the surrounding census tract was 
correlated with several purchase behaviors. Specifically, the census tract median income was 
associated with a higher total amount spent and a lower likelihood of purchasing only loose-leaf 
buds. These findings are similar to those observed for purchase of edibles (Kepple & Freisthler, 
2017). Given its correlation with product diversity and exterior maintenance, census tract median 
income may be serving as a proxy for the overall appeal of the location to consumers and the 
diversity of products being offered. Future work on venue-level features should explore 
developing refined measures of perceived popularity or legitimacy of a location, product 
diversity, promotional deals, and niche market indicators to build upon these findings.  
Strengths and Limitations 
Although these findings provide insight into purchase behaviors and their correlates, 
readers should interpret them in light of the study’s limitations. First, data for this study included 
a single visit to a sampled MMDs. They cannot address whether purchase behavior varied based 
on how often the patron visited the dispensary. We also do not know whether the purchases we 
captured were typical for those patrons. This limitation is offset by the reduction of recall bias 
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and ability to identify venue-specific traits through asking patrons to report on purchase 
behaviors at the time of their exit from the dispensary. Second, we did not examine correlates of 
price per gram for marijuana buds or other variations in potency within each product type. These 
measures may provide insight into MMD- and individual-level correlates related to patrons who 
obtain higher potency or higher quality products. Third, the study did not include measures that 
can help us better understand factors influencing purchase behavior, such as the comparative 
costs of products across dispensary locations, specific marketing strategies used within the 
venue, patrons’ motivations for purchase, or patrons’ intent to share with others. Further work 
exploring more precise measures of venue- and patron-specific characteristics is important if we 
are to understand the ways that place influences behaviors and how this information can be 
leveraged for effective place-based regulations and targeted prevention efforts.  
Finally, California passed legislation in 2016 that permits recreational use in addition to 
medical use of marijuana (National Conference of State Legislatures, 2018). As a result, future 
dispensary models and purchasing behaviors may shift with changing policies. For example, 
states that have recreational use laws generally have separate systems for medical users (e.g., 
taxed less, required to register) and separate licensure and site requirements for dispensaries. 
That being said, MMDs currently remain the prevailing licit distribution model for marijuana 
across the United States (National Conference of State Legislatures, 2018). 
Implications 
Our study’s findings can help policy makers and community practitioners begin to think 
about the nature and function of this newer type of drug outlet in order to create more effective 
place-based policies and target prevention efforts. For example, policy makers may want to 
explore regulating the availability of specialty items that may be attractive to naïve users (e.g., 
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pre-rolled joints) or high-concentration products that may be sought out by regular, heavy users. 
In addition, caps on quantities obtained may help to mitigate marijuana-related harms. These 
caps would align with recommendations against consumption of high doses to address medical 
conditions and with concerns that these doses may suggest tolerance or misuse (MacCallum & 
Russo, 2018). Further, caps would affect a small proportion of users given the vast majority of 
patrons reported relatively low quantities per purchase (1g to 8g). Regulations focused on 
limiting the quantity of a single purchase or purchases within a specified time frame—which is 
how pseudoephedrine is currently administered—might also reduce the possible consequences of 
maintaining a large supply of cannabis, such as overconsumption or an unintentional diversion of 
the product. Thirdly, inconsistencies in local licensing practices may be contributing to patrons 
travelling considerable distances because of limited availability of dispensaries near their homes 
or limited product diversity at dispensaries proximal to their homes. Finally, prevention efforts, 
such as those focused on deterring driving while under the influence of cannabis or educating 
individuals about safe consumption of concentrates, are likely to reach their intended audience if 
they target their efforts in areas surrounding dispensary sites (Berg et al., 2018).  
Conclusions 
As licit distribution of marijuana through placed-based venues expands, there is an 
ongoing need to understand how patrons are engaging these outlets and accessing marijuana 
products. This study provided insight into products purchased from MMDs within one regional 
context, emphasizing the importance of understanding the places where marijuana is being 
distributed as well as the individuals who obtain these products.  
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Table 1  
Sample Characteristics for Respondents (N = 595) 
 
Sample Characteristics n(%) or M(SD) Min Max 
   Gender    
        Male 457 (76.8)   
        Female 136 (22.9)   
        Missing 2 (0.3)   
   Age (in years) 34.1 (12.9) 18 80 
       18 to 24 177 (29.7)   
       25 to 34 182 (30.6)   
       35 to 54 181 (30.4)   
       55 or older 53 (8.9)   
       Missing 2 (0.3)   
   Race/Ethnicity    
        White NH 188 (31.6)   
        Black NH 183 (30.8)   
        Hispanic/Latino 158 (26.6)   
        Asian/Pacific Islander NH 22 (3.7)   
        American Indian/Alaskan Native NH 4 (0.7)   
        Other race NH 23 (3.9)   
        Two or more races NH 16 (2.7)   
        Missing 1 (0.2)   
  Has medical marijuana recommendation?    
        No 4 (0.7)   
        Yes 588 (98.8)   
        Missing 3 (0.5)   
  Reason for medical marijuana use    
        Pain 323 (54.3)   
        Mental health condition 354 (59.5)   
        Gastrointestinal condition 95 (16.0)   
        Neurologic condition 72 (12.1)   
        Other chronic medical condition 43 (7.2)   
        Non-medical conditions 9 (1.5)   
        Not Reported 7 (1.2)   
  Distance from Home to MMD (km) 13.2 (23.9) 0.0 110.7 
Note. NH = Non-Hispanic 
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Table 2  
 
Sample Characteristics for MMDs (N = 16) 
 
Sample Characteristics n(%) or M(SD) Min Max 
   Census tract pop density (1,000 pop per sq mi) 14.7 (9.6) 3.0 36.4 
   Census tract median income (in US $1,000) 57.1 (29.0) 23.6 119.9 
   Census tract % pop White and non-Hispanic 30.1 (30.1) 0.1 78.7 
   Surrounding MMD density (count within 0.5 km) 2.6 (1.8) 1.0 8.0 
   MMD licensure status    
       Opened pre-ICO and remains eligible 2 (12.5)   
       Opened pre-ICO but now ineligible 4 (25.0)   
       Opened post-ICO 10 (62.5)   
   MMD exterior maintenance     
        Poor to fair 5 (31.3)   
        Good to excellent 11 (68.8)   
   MMD number of security features  2.1 (1.3) 0.0 4.0 
        Locked metal screen door 6 (37.5)   
        Pass-through door 8 (50.0)   
        Intercom 2 (12.5)   
        Doorman 1 (6.3)   
        Security cameras 15 (93.8)   
        Signage about IDs/Rx required 2 (12.5)   
   MMD payment options    
       Cash only 11 (68.8)   
       Credit card accepted 5 (31.3)   
   Diversity of products sold    
       Low (primarily buds) 2 (12.5)   
       Moderate (mix of products) 7 (43.8)   
       High (all types of products sold) 7 (43.8)   
   Average price for 1g of indica (in US $) (n = 12)    
         Low end average 6.5 (2.9) 1.0 10.0 
         High end average 20.4 (2.5) 17.0 25.0 
   Average price for 1g sativa (in US $) (n = 12)    
         Low end average 8.4 (3.9) 2.0 15.0 
         High end average 17.3 (3.7) 10.0 25.0 
   Average price for 1g hybrid (in US $) (n = 10)    
         Low end average 7.7 (4.5) 0.0 15.0 
         High end average 17.5 (3.8) 10.0 22.0 
Note. MMD = medical marijuana dispensary 
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Table 3  
 
Respondent Self-Reported Discrete Purchase Behaviors 
 
Purchase Behaviors n(%) or M(SD) Min Max 
Purchased any item? (n = 595)    
      No 47 (7.9)   
      Yes 547 (91.9)   
      Missing 1 (0.2)   
    
Among purchasers (n = 547)    
  Total amount spent in $US (n = 535) 41.7 (43.9) 0.0 330.0 
  Type of products purchased     
     Buds 500 (91.4)   
     Edibles 66 (12.1)   
     Pre-rolled joints      62 (11.3)   
     Concentrates 46 (8.4)   
     Seeds or clones 17 (3.1)   
  Multiple types purchased    
      Zero to one type of product 421 (77.0)   
      Two or more types of products 126 (23.0)   
    
Among bud purchasers (n = 500)    
  Quantity of buds in grams (n = 492) 4.4 (6.0) 1.0  56.0 
  Strain of buds purchased     
     Indica 278 (55.6)   
     Sativa 185 (37.0)   
     Hybrid  128 (25.6)   
  Number of strains purchased     
     One strain 416 (83.2)   
     Two or more strains 84 (16.8)   
 
  
MMD Purchases in Los Angeles   28 
 
Table 4  
 
Correlates of Total Amount Spent (LN$US) (n = 517) 
 
 b  SE p exp(b)  
Model for Level 2 (MMD Means)     
   Intercept 2.873 0.233 < .001 17.697 
   Mean CT median income (US $1,000) 0.007 0.002 .007 1.007 
   MMD density (count within 0.5 km) 0.011 0.040 .781 1.011 
     
Models for Level 1 (Variable Slopes)     
Patron demographics     
   Male -0.045 0.083 .589 0.956 
   Age (in years)     
        18 to 24 ref    
        25 to 34 0.228 0.091 .013 1.256 
        35 to 54 0.276 0.094 .003 1.318 
        55 or older 0.297 0.136 .029 1.346 
   Race/ethnicity     
        White and non-Hispanic ref    
        Black and non-Hispanic -0.409 0.102 < .001 0.664 
        Hispanic -0.266 0.100 .008 0.766 
        Other race/ethnicity -0.037 0.121 .759 0.964 
Purchase behaviors     
   Purchased edibles -0.322 0.140 .022 0.725 
   Purchased seeds/clones -0.162 0.219 .460 0.850 
   Purchased pre-rolled joints -0.717 0.138 < .001 0.488 
   Purchased concentrates 0.095 0.146 .514 1.100 
   Multiple types of products 0.624 0.142 < .001 1.866 
Medical conditions      
   Use for Pain -0.119 0.079 .132 0.888 
   Use for mental health condition -0.043 0.081 .597 0.958 
   Use for gastrointestinal condition -0.261 0.096 .007 0.770 
   Use for neurological condition -0.339 0.106 .001 0.713 
   Use for other chronic medical condition -0.240 0.135 .075 0.786 
Travel distance     
   Distance from home to MMD (log-meter) 0.082 0.021 < .001 1.085 
Random Effects 
Variance 
Component df χ2 p 
   MMD Means, u0 0.043 13 44.094 < .001 
   Level-1 effect, r 0.579    
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Note. Dependent variable is transformed using a natural log function to approximate a normal 
distribution and analyzed using a hierarchical linear model; MMD = medical marijuana 
dispensary; CT = census tract. 
 
  
MMD Purchases in Los Angeles   30 
 
 
Table 5  
 
Correlates of Total Grams of Marijuana Buds Purchased (N = 483) 
 
 b  SE p ERR 
Model for Level 2 (MMD Means)     
   Intercept -0.142 0.186 0.459 0.867 
   Mean CT median income (US $1,000) 0.000 0.003 0.952 1.000 
   MMD density (count within 0.5 km) -0.011 0.057 0.844 0.989 
     
Models for Level 1 (Variable Slopes)     
Patron demographics     
   Male 0.111 0.055 0.043 1.118 
   Age (in years)     
        18 to 24 ref   ref 
        25 to 34 0.337 0.062 < .001 1.401 
        35 to 54 0.333 0.064 < .001 1.395 
        55 or more 0.512 0.092 < .001 1.669 
   Race/ethnicity     
        White and non-Hispanic ref   ref 
        Black and non-Hispanic -0.502 0.072 < .001 0.605 
        Hispanic -0.004 0.061 .949 0.996 
        Other race/ethnicity -0.200 0.078 .011 0.819 
Purchase behaviors     
   Purchased buds only -0.117 0.052 .025 0.890 
   Purchased multiple strains 0.694 0.053 < .001 2.002 
Medical conditions     
   Use for pain 0.031 0.052 .547 1.032 
   Use for mental health condition -0.024 0.055 .659 0.976 
   Use for gastrointestinal condition -0.198 0.068 .004 0.820 
   Use for neurological condition 0.077 0.066 .244 1.080 
   Use for other chronic medical condition -0.013 0.091 .888 0.987 
Travel distance     
   Distance from home to MMD (log-meter) 0.156 0.014 < .001 1.169 
Random Effects 
Variance 
Component df χ2 p 
   MMD means, u0 0.137 13 321.677 < .001 
Note. Dependent variable is modeled as a count in grams and analyzed using a hierarchical 
generalized linear model with Poisson sampling and log-link function; ERR = event rate ratio; 
MMD = medical marijuana dispensary; CT = census tract.
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Supplemental Table A1 
 
Adjusted HGLM for Purchasing Buds Only (N = 517) 
 
 b  SE p OR  
Model for Level 2 (MMD Means)     
   Intercept 1.253 0.723 .106 3.503 
   Mean CT median income (US $1,000) -0.017 0.007 .021 0.983 
   MMD density (count within 0.5 km) -0.161 0.116 .187 0.851 
     
Models for Level 1 (Variable Slopes)     
Patron demographics     
   Male -0.287 0.263 .277 0.751 
   Age (in years)     
        18 to 24 ref    
        25 to 34 -0.242 0.284 .394 0.785 
        35 to 54 -0.103 0.291 .724 0.902 
        55 or more 0.470 0.436 .282 1.600 
   Race/ethnicity     
        White and non-Hispanic ref    
        Black and non-Hispanic 0.563 0.310 .070 1.755 
        Hispanic 0.404 0.295 .171 1.498 
        Other race/ethnicity 0.011 0.347 .976 1.011 
Medical conditions      
   Use for pain 0.036 0.242 .882 1.036 
   Use for mental health condition 0.269 0.251 .285 1.309 
   Use for gastrointestinal condition 0.185 0.297 .535 1.203 
   Use for neurological condition -0.345 0.314 .274 0.708 
   Use for other chronic medical condition -0.433 0.391 .269 0.649 
Travel distance     
   Distance from home to MMD (log-meter) -0.048 0.066 .470 0.954 
Random Effects 
Variance 
Component df χ2 p 
   MMD means, u0 0.362 13 39.626 < .001 
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Supplemental Table A2  
 
Adjusted HGLM for Purchasing Pre-Rolled Joints (N = 517) 
 
 b  SE p OR  
Model for Level 2 (MMD Means)     
   Intercept -2.068 0.961 .051 0.126 
   Mean CT median income (US $1,000) 0.007 0.008 .441 1.007 
   MMD density (count within 0.5 km) 0.022 0.150 .884 1.022 
     
Models for Level 1 (Variable Slopes)     
Patron demographics     
   Male 0.290 0.360 .422 1.336 
   Age (in years)     
        18 to 24 ref    
        25 to 34 -0.615 0.407 .132 0.541 
        35 to 54 -0.196 0.377 .603 0.822 
        55 or more -0.268 0.559 .631 0.765 
   Race/ethnicity     
        White and non-Hispanic ref    
        Black and non-Hispanic -0.226 0.417 .589 0.780 
        Hispanic -0.225 0.398 .572 0.799 
        Other race/ethnicity -0.937 0.584 .110 0.392 
Medical conditions      
   Use for pain -0.287 .330 .386 0.751 
   Use for mental health condition -0.520 .334 .120 0.593 
   Use for gastrointestinal condition -0.130 .416 .756 0.878 
   Use for neurological condition 0.520 .399 .193 1.682 
   Use for other chronic medical condition 0.923 .467 .048 2.518 
Travel distance     
   Distance from home to MMD (log-meter) 0.057 .088 .519 1.059 
Random Effects 
Variance 
Component df χ2 p 
   MMD means, u0 0.499 13 32.040 .003 
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Supplemental Table A3 
 
Unadjusted HGLMs for Purchasing Concentrates (N = 517) 
 
 b  SE p OR  
By gender     
   Intercept -3.398 0.526 < .001 0.033 
   Male 1.105 0.539 .041 3.019 
     
By age     
   Intercept -2.800 0.372 < .001 0.061 
   Age (in years)     
        18 to 24 Ref    
        25 to 34 0.736 0.432 .089 2.088 
        35 to 54 0.227 0.465 .626 1.254 
        55 or more -0.001 0.699 .999 0.999 
     
By race/ethnicitya     
   Intercept -2.754 0.241 < .001 0.064 
   White and non-Hispanic 0.786 0.335 .019 2.196 
     
Obtained multiple types of products?     
   Intercept -3.780 0.352 < .001 0.023 
   Multiple types 2.802 0.400 < .001 16.479 
     
Obtained loose-leaf buds?     
   Intercept -0.856 0.348 .027 0.425 
   Buds -1.882 0.391 < .001 0.152 
     
Medical conditions     
   Intercept -2.629 0.437 < .001 0.072 
   Use for pain 0.056 0.358 .876 1.057 
   Use for mental health 0.093 0.376 .806 1.097 
   Use for gastrointestinal  -0.038 0.445 .931 0.962 
   Use for neurological  -0.351 0.447 .433 1.420 
   Use for other chronic medical 0.346 0.576 .549 1.413 
     
Distance travelled     
    Intercept -2.956 0.852 .003 0.052 
    Distance travelled (log-meter) 0.053 0.099 .556 1.060 
a Model does not converge with expanded categories. 
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Supplemental Table B1 
Zero Order Correlation of Medical Conditions (N = 517) 
 
Pain 
Mental 
Health Gastro Neuro 
Other 
Chronic 
Non-
medical 
Pain --      
Mental Health    - .417* --     
Gastro    - .123*       .145* --    
Neuro    - .086       .038       .070 --   
Other Chronic    - .062    - .149*       .066    - .064 --  
Non-medical    - .026       .045    - .019      .083    - .038 -- 
* p < .05 
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Supplemental Table B2 
Unadjusted HLMs for Medical Conditions & Total Amount Spent (N = 517) 
 b  SE p 
Used for pain    
   Intercept 3.371 0.111 < .001 
   Pain -0.067 0.075 .372 
    
Used for mental health    
   Intercept 3.330 0.114 < .001 
   Mental health 0.008 0.077 .916 
    
Used for gastrointestinal conditions    
   Intercept 3.381 0.107 < .001 
   Gastrointestinal -0.301 0.101 .003 
    
Used for neurological conditions    
   Intercept 3.370 0.105 < .001 
   Neurological -0.289 0.111 .010 
    
Used for other chronic medical 
Conditions  
  
   Intercept 3.340 0.104 < .001 
   Other chronic medical -0.074 0.140 .595 
    
Used for non-medical conditions    
   Intercept 3.333 0.103 < .001 
   Non-medical 0.106 0.284 .709 
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Supplemental Table B3 
Model Building for Adjusted HLMs for Total Amount Spent (N = 517) 
 No Medical 
Conditions 
b (SE) 
Gastro + 
Neuro 
b (SE) 
All Med 
Conditions 
Model for Level 2 (MMD Means)    
   Intercept 2.70 (0.22) 2.82 (0.22) 2.87 (0.23) 
   Mean CT median income ($1,000) 0.01 (0.00) 0.01 (0.00) 0.01 (0.00) 
   MMD density (count w/in 0.5 km) 0.02 (0.04) 0.02 (0.04) 0.01 (0.04) 
    
Models for Level 1 (Variable Slopes)    
Patron demographics    
   Male -0.01 (0.08) -0.04 (0.08) -0.05 (0.08) 
   Age (in years)    
        18 to 24 ref ref ref 
        25 to 34 0.22 (0.09) 0.22 (0.09) 0.23 (0.09) 
        35 to 54 0.24 (0.09) 0.25 (0.09) 0.28 (0.09) 
        55 or more 0.26 (0.14) 0.27 (0.13) 0.29 (0.14) 
   Race/ethnicity    
        White and non-Hispanic ref Ref Ref 
        Black and non-Hispanic -0.44 (0.10) -0.43 (0.10) -0.41 (0.10) 
        Hispanic -0.28 (0.10) -0.28 (0.10) -0.27 (0.10) 
        Other race/ethnicity -0.06 (0.12) -0.05 (0.12) -0.04 (0.12) 
Purchase behaviors    
   Purchased edibles -0.33 (0.14) -0.32 (0.14) -0.32 (0.14) 
   Purchased seeds/clone -0.17 (0.22) -0.16 (0.22) -0.16 (0.22) 
   Purchased pre-rolled joints -0.75 (0.14) -0.73 (0.14) -0.72 (0.14) 
   Purchased concentrates 0.07 (0.15) 0.08 (0.15) 0.10 (0.15) 
   Multiple types of products 0.64 (0.14) 0.63 (0.14) 0.62 (0.14) 
Medical conditions     
   Use for pain   -0.12 (0.08) 
   Use for mental health condition   -0.04 (0.08) 
   Use for gastrointestinal condition  -0.24 (0.10) -0.26 (0.10) 
   Use for neurological condition  -0.31 (0.10) -0.34 (0.11) 
   Use for other chronic medical    -0.24 (0.14) 
Travel distance    
   Distance from home to MMD  
         (log-meter) 0.08 (0.02) 0.08 (0.02) 0.08 (0.02) 
Note: Significant coefficients are bolded. 
